Connecting prognostic ligand receptor signaling loops in advanced ovarian cancer.
Understanding cancer cell signal transduction is a promising lead for uncovering therapeutic targets and building treatment-specific markers for epithelial ovarian cancer. To brodaly assay the many known transmembrane receptor systems, previous studies have employed gene expression data measured on...
Main Authors: | Kevin H Eng, Christina Ruggeri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0107193 |
Similar Items
-
Inferring Active and Prognostic Ligand-Receptor Pairs with Interactions in Survival Regression Models
by: Christina Ruggeri, et al.
Published: (2014-01-01) -
Inferring Active and Prognostic Ligand-Receptor Pairs with Interactions in Survival Regression Models
by: Christina Ruggeri, et al.
Published: (2015-01-01) -
Differential antigen expression profile predicts immunoreactive subset of advanced ovarian cancers.
by: Kevin H Eng, et al.
Published: (2014-01-01) -
Roles of epidermal growth factor receptor and its ligands in ovarian cancer
by: Xin, Qiu
Published: (2015) -
Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
by: Hong Zheng, et al.
Published: (2013-09-01)